July 31, 2025 Uncategorized No Comments Mondego Bio Presents Promising Preclinical Data on PTPN2 Inhibitor ZE00-0388 at EMBO Workshop Mondego Bio today announced preliminary safety and efficacy results for its leading PTPN2 inhibitor, ZE00-0388, presented at the EMBO Workshop Phosphatases: From Basic Research to Translation (July 27–31, 2025, Würzburg, Germany). Read more
